Research Article
Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial
Table 6
Outcomes of patients in the clopidogrel and ticagrelor groups.
| | Clopidogrel (n = 223) | Ticagrelor (n = 214) | value |
| Major adverse cardiac events | 17 (7.6%) | 6 (2.8%) | 0.031 | Acute coronary syndrome, n (%) | 14 (6.2%) | 6 (2.8%) | | Heart failure, n (%) | 1 (0.4%) | 0 | | Cerebrovascular events, n (%) | 1 (0.4%) | 0 | | Cardiac death, n (%) | 1 (0.4%) | 0 | | Noncardiac death, n (%) | 3 (1.3%) | 1 (0.4%) | 0.371 | Bleeding, n (%) | 7 (3.2%) | 8 (3.8%) | 0.799 |
|
|